Episode 237: June Retinal Physician, Port Delivery System Home Screening during COVID-19 and More

Dr. Daniel Chao joins for a discussion on the June 2020 issue of Retinal Physician including a discussion of the recent press release regarding the anti-VEGF port delivery system phase 3 trial results, scleral buckling pearls, vitrectomy for macular edema, photic retinopathy and home screening for macular degeneration during the COVID-19 pandemic.

Financial Disclosures: Dr. Sridhar is a consultant for Regeneron and Alcon. Dr. Chao is a consultant and has received research funding from Genentech.

CME Information

Release: June 1, 2020; expires June 1, 2023

Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD

Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.